Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Ascend Communications (ASND) -- Ignore unavailable to you. Want to Upgrade?

To: TideGlider who wrote (48550)	6/11/1998 11:51:00 AM
From: WBendus	Read Replies (3) \| Respond to of 61433

PG has got problems with the Center for Science and Public Interst (CSPI) claiming that PG is severely understating the gastrointestinal problems associated with Olestra. "WASHINGTON, June 10 (Reuters) - A group that has been campaigning against olestra, the new ''fat-free'' fat, renewed its assault on Wednesday, saying long-term use of the product may cause thousands of cancer cases." Besides, PG is allready in the dow and S&P, therefore being added to the OEX will not provide all that much support. Wayde.